| Page 97 | Kisaco Research

Machine learning is reshaping discovery science in Human Health and Organicin Scientific is proving its potential in animal health too. Mat Mitchell, Co-Founder and CTO, shares how Organicin Scientific’s machine-learning platform automates candidate selection to identify, evaluate, and commercialise novel antimicrobials for safe and sustainable use across the industry.

Machine Learning
R&D
Drug Discovery
Antimicrobial
AI

Author:

Mathew Mitchell

Co-Founder and CTO
Organicin Scientific

Mathew Mitchell

Co-Founder and CTO
Organicin Scientific